Potential for efficacy of the oncolytic
โ
Alastair T. M. Mace; Ian Ganly; David S. Soutar; S. Moira Brown
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 96 KB
๐ 1 views
## Abstract ## Background. Herpes simplex virus (HSV) 1716 is a selectively replicating oncolytic virus. Our objective was to assess the potential efficacy of HSV1716 in patients with oral squamous cell carcinoma (SCC) by intratumoral injection. ## Methods. Twenty patients with oral SCC had a si